Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

PRC2

  • You have access
    Wedelolactone Targets EZH2-mediated Histone H3K27 Methylation in Mantle Cell Lymphoma
    NADEZHDA ROMANCHIKOVA and PETERIS TRAPENCIERIS
    Anticancer Research August 2019, 39 (8) 4179-4184; DOI: https://doi.org/10.21873/anticanres.13577
  • You have access
    3-Deazaneplanocin A May Directly Target Putative Cancer Stem Cells in Biliary Tract Cancer
    CHRISTIAN MAYR, ANDREJ WAGNER, ANGELIKA STOECKLINGER, MARTIN JAKAB, ROMANA ILLIG, FRIEDER BERR, MARTIN PICHLER, PIETRO DI FAZIO, MATTHIAS OCKER, DANIEL NEUREITER and TOBIAS KIESSLICH
    Anticancer Research September 2015, 35 (9) 4697-4705;
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire